港A市場電子煙概念股集體大漲 華寶國際大漲19% 思摩爾再創新高
格隆匯1月19日丨A股美盈森、東風股份、陝西金葉、勁嘉股份漲停,華寶股份逼近漲停,集友股份、順灝股份均有明顯上漲。港股中國波頓漲25%,華寶國際漲19%,入選了格隆匯2021年“下注中國”十大核心潛力資產的思摩爾漲超8%再創歷史新高。據悉,中國最大電子煙製造商、知名電子煙品牌悦刻的主體公司霧芯科技申請赴美國進行首次公開募股(IPO),融資至多11.7億美元。悦刻是思摩爾的大客户,公司獨家供應陶瓷芯。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.